Dockets

Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment

Suspicious Orders of Controlled Substances

Regulation of Telepharmacy Practice

Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I

Exempt Chemical Preparations Under the Controlled Substances Act (DEA372)

Providing CS to Ocean Vessels, Aircraft, and Other Entities

Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)

Controlled Substances Ordering System Modernization (DEA732)

Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948)

Telemedicine Prescribing of Controlled Substances (DEA407)

Definition of ‘‘Cannabimimetic Agents’’ and Assignment of an Administration Controlled Substances Code Number for All ‘‘Cannabimimetic Agents’’ (DEA368)

Special Surveillance List of Chemicals, Products, Materials and Equipment Used in the Manufacture of Controlled Substances and Listed Chemicals (DEA1086)